Saturday, October 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Nel ASA Faces Critical Test as Orders Collapse and CEO Vacancy Clouds Pre-Results Silence

Kennethcix by Kennethcix
July 1, 2026
in Earnings, European Markets, Hydrogen
0
Nel ASA Stock
0
SHARES
27
VIEWS
Share on FacebookShare on Twitter

The Norwegian electrolyser maker has entered its statutory quiet period ahead of half-year results due on July 15, locking out investor communications at a moment of acute stress. The blackout coincides with the aftermath of chief executive Håkon Volldal’s resignation on June 15, leaving the company without a permanent successor and the market without a clear compass.

Volldal remains at the helm during his six-month notice period, but the search for a replacement creates an unwelcome leadership vacuum. Nel’s board insists the strategic direction remains unchanged, yet without direct access to management, shareholders find it impossible to gauge progress on hydrogen project rollouts. The resulting uncertainty has already exacted a heavy toll on the stock.

Over the past 30 days, shares have shed more than 35% of their value, touching €0.21 — precisely the 200-day moving average. A decisive break below that technical support would risk a slide toward the year’s low of €0.17, a level that would represent another 19% decline from current prices. The price action reflects a market starving for fresh catalyst until the mid-July report.

Should investors sell immediately? Or is it worth buying Nel ASA?

The fundamental picture from the first quarter offers little comfort. Revenue from customer contracts slipped 5% year-on-year to NOK 148 million, while the operating loss narrowed by NOK 15 million to minus NOK 100 million. More worrying, new order intake collapsed to just NOK 85 million — a 73% plunge from the NOK 312 million recorded a year earlier. The order backlog, a key forward-looking indicator, stood at around NOK 1.1 billion at the end of March.

That backlog provides some visibility, but the cash burn rate raises further questions. Nel ended the quarter with liquid assets of roughly NOK 1.4 billion, against an operational cash outflow of NOK 165 million over the same period. Investors will scrutinise the half-year numbers for evidence that both the order trajectory and the cost discipline are stabilising.

Until July 15, the company is effectively in radio silence. The big test is whether the upcoming report can show a rebound in order intake and tighter control on expenses. If those core metrics disappoint, the €0.17 floor could come into play. For now, the stock is balancing on a technical and fundamental knife-edge.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from October 2 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 2.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Kennethcix

Kennethcix

Related Posts

Siemens Energy Stock
Energy & Oil

Siemens Energy: Nuclear Ambitions Meet Chart Warnings as CEO Urges Crisis Preparedness

September 7, 2026
TKMS Stock
Defense & Aerospace

TKMS Closes the Dolphin Chapter and Courts Fincantieri — But Shareholders Are Still Waiting for the Tide to Turn

September 7, 2026
Hensoldt Stock
Defense & Aerospace

Hensoldt’s €10 Billion Backlog Meets a 32% Drawdown: The Bull-Bear Fault Line Widening in Taufkirchen

September 7, 2026
Next Post
Vanguard FTSE All-World UCITS ETF USD Accumulation Stock

Vanguard All-World ETF Edges Towards Record as FTSE Russell Ousts Indonesian Stocks and DWS Fires Fee Salvo

Microsoft Stock

Microsoft Accelerates Quantum Security Timeline Amid $100 Billion AI Pivot and 5,500 Job Cuts

Texas Instruments Stock

New Quarter, Old Pattern: July's Rally Meets Big Tech's Next Move

Recommended

Ocugen Stock

Ocugen’s Divergent Paths: Analyst Optimism Meets Merger Setback

1 year ago
InnoCan Pharma Stock

InnoCan Pharma’s Breakthrough Study Fuels Nasdaq Ambitions

11 months ago
Dow Jones Stock

A Rally on Shaky Ground: The Dow’s Thin Tuesday Gains

10 months ago
Red Cat Stock

Red Cat Equity Offering Sparks Investor Concerns

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

The K-Shaped Economy Meets a 19-Year High in Yields

Consumer Strength Meets Bond Market Stress Ahead of Q4

Borrowed Bull: Record Margin Debt Meets a Record Foreign Inflow

Software Over Silicon: Microsoft’s Bet to Monetize the AI Boom

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

From Chips to Chains: Crypto Becomes Finance’s New Backbone

Trending

Nike Stock
Newsletter

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

by Stephanie Dugan
October 2, 2026
0

Dear readers, Nike's answer to the question we left open yesterday is in, and it isn't kind....

Alphabet Stock

From GPUs to Guardrails: Q4’s Security Rotation Begins

October 1, 2026
Charles Schwab Stock

The Rate Plateau’s Real Winners Aren’t Chipmakers

September 30, 2026
Nvidia Stock

The K-Shaped Economy Meets a 19-Year High in Yields

September 29, 2026
Twilio Stock

Consumer Strength Meets Bond Market Stress Ahead of Q4

September 28, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers
  • From GPUs to Guardrails: Q4’s Security Rotation Begins
  • The Rate Plateau’s Real Winners Aren’t Chipmakers

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com